Total debt has ranged from roughly $5.2B to $9.9B while shareholder equity stayed negative at about -$3.0B, and the current ratio of 0.88 indicates short-term liabilities that consistently meet or exceed current assets.
Cardinal Health, Inc. (CAH) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Jun'26 | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 | Jun'08 | Jun'07 | Jun'06 | Jun'05 | Jun'04 | Jun'03 | Jun'02 | Jun'01 | Jun'00 | Jun'99 | Jun'98 | Jun'97 |
|---|
| Total Current Assets | 40.99B | 38.75B | 36.37B | 34.88B | 33.74B | 32.94B | 31.05B | 25.94B | 25.75B | 24.55B | 28.34B | 21.96B | 21.75B | 17.94B | 17.77B | 17.51B | 16.32B | 14.92B | 20.98B | 14.28B | 14.54B | 16.58B | 13.53B | 13.06B | 13.25B | 11.91B | 10.72B | 8.45B | 5.2B | 4.79B | 2.49B |
| Cash & Short-Term Investments | 5.26B | 4.86B | 3.87B | 5.13B | 4.08B | 4.72B | 3.41B | 2.77B | 2.53B | 1.76B | 6.88B | 2.36B | 4.62B | 2.87B | 1.9B | 2.27B | 1.93B | 2.76B | 1.22B | 1.68B | 1.44B | 1.69B | 1.5B | 1.1B | 1.72B | 1.38B | 934.1M | 539.5M | 185.4M | 373.3M | 243.1M |
| Cash Only | 5.26B | 4.86B | 3.87B | 5.13B | 4.08B | 4.72B | 3.41B | 2.77B | 2.53B | 1.76B | 6.88B | 2.36B | 4.62B | 2.87B | 1.9B | 2.27B | 1.93B | 2.76B | 1.22B | 1.29B | 1.31B | 1.19B | 1.4B | 1.1B | 1.72B | 1.38B | 934.1M | 539.5M | 185.4M | 373.3M | 243.1M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 383.7M | 132M | 498.4M | 99.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 14.54B | 13.81B | 13.24B | 12.08B | 11.11B | 10.57B | 9.1B | 8.26B | 8.45B | 7.8B | 8.05B | 7.41B | 6.52B | 5.38B | 6.3B | 6.36B | 6.16B | 5.17B | 5.21B | 4.99B | 4.71B | 3.81B | 3.1B | 3.43B | 2.78B | 2.3B | 2.41B | 2.4B | 1.6B | 1.44B | 672.2M |
| Days Sales Outstanding | 19.71 | 19.83 | 21.72 | 19.45 | 19.78 | 21.28 | 20.45 | 19.72 | 21.19 | 20.81 | 22.6 | 22.24 | 23.22 | 21.56 | 22.76 | 21.57 | 21.89 | 19.16 | 19.83 | 20.83 | 19.81 | 17.45 | 15.58 | 19.42 | 17.91 | 16.38 | 18.34 | 22.83 | 23.29 | 24.87 | 13.34 |
| Inventory | 18.39B | 17.3B | 16.83B | 14.96B | 16.12B | 15.64B | 14.59B | 13.2B | 12.82B | 12.31B | 11.3B | 10.62B | 9.21B | 8.27B | 8.37B | 7.86B | 7.33B | 6.36B | 6.83B | 6.77B | 7.38B | 7.49B | 7.25B | 7.47B | 7.62B | 7.36B | 6.29B | 4.66B | 2.94B | 2.61B | 1.44B |
| Days Inventory Outstanding | 27.19 | 25.82 | 28.65 | 24.88 | 29.7 | 32.64 | 34.21 | 32.98 | 33.74 | 34.66 | 33.42 | 33.69 | 34.72 | 35.11 | 31.78 | 27.86 | 27.18 | 24.49 | 27.04 | 29.54 | 33.02 | 36.54 | 38.79 | 45.54 | 53.25 | 57.06 | 51.75 | 48.22 | 48.23 | 51.19 | 32.43 |
| Other Current Assets | 2.79B | 21M | 2.43B | 2.71B | 72M | 36M | 1.1B | 0 | 0 | 756M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.19B | 264.2M | 354.8M | 3.03B | 1.05B | 262.5M | 341.9M | 218.3M | 236.3M | 851.1M | 473.1M | 368.4M | 135.6M |
| Total Non-Current Assets | 18.55B | 18.55B | 16.75B | 10.24B | 9.61B | 10.94B | 13.4B | 14.83B | 15.22B | 15.4B | 11.77B | 12.17B | 8.39B | 8.09B | 8.05B | 6.75B | 6.53B | 5.07B | 4.14B | 9.17B | 8.61B | 6.86B | 8.31B | 8.31B | 5.27B | 4.53B | 3.93B | 3.58B | 3.2B | 2.69B | 604.7M |
| Property, Plant & Equipment | 3B | 4.02B | 2.86B | 2.53B | 2.46B | 2.36B | 2.36B | 2.37B | 2.36B | 2.49B | 1.88B | 1.8B | 1.51B | 1.46B | 1.49B | 1.55B | 1.51B | 1.47B | 1.46B | 1.74B | 1.65B | 1.5B | 2.48B | 2.36B | 2.09B | 1.89B | 1.84B | 1.73B | 1.56B | 1.47B | 277.5M |
| Fixed Asset Turnover | 80.38x | 63.21x | 77.88x | 89.69x | 83.29x | 76.80x | 68.84x | 64.63x | 61.77x | 55.01x | 69.17x | 67.68x | 68.08x | 62.43x | 67.89x | 69.34x | 67.88x | 67.06x | 65.55x | 50.32x | 52.73x | 52.93x | 29.25x | 27.29x | 27.15x | 26.99x | 26.08x | 22.19x | 16.08x | 14.36x | 66.28x |
| Goodwill | 11.54B | 13.63B | 9.69B | 4.72B | 4.61B | 5.86B | 7.99B | 8.36B | 8.38B | 8.32B | 7.22B | 7.17B | 5.07B | 4.88B | 4.6B | 3.98B | 3.85B | 2.25B | 2.27B | 6.16B | 5.86B | 4.28B | 4.84B | 0 | 0 | 0 | 1.18B | 0 | 0 | 0 | 0 |
| Intangible Assets | 2.15B | 0 | 2.49B | 1.73B | 1.47B | 1.77B | 2.1B | 2.92B | 3.43B | 3.91B | 1.99B | 2.26B | 948M | 992M | 973M | 414M | 413M | 0 | 0 | 0 | 0 | 0 | 0 | 4.94B | 2.33B | 1.54B | 0 | 1.04B | 942.1M | 850.5M | 122.1M |
| Long-Term Investments | 0 | 0 | 14M | 43M | 56M | 77M | 68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 691.5M | 0 | 916.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.87B | 893M | 1.7B | 1.22B | 1.01B | 876M | 883M | 1.19B | 1.05B | 682M | 681M | 944M | 866M | 765M | 986M | 807M | 759M | 657.8M | 405.7M | 384.1M | 1.1B | 1.07B | 1.02B | 1.01B | 846.1M | 1.09B | 912.4M | 805.7M | 700.3M | 373.7M | 205.1M |
| Total Assets | 59.54B | 57.3B | 53.12B | 45.12B | 43.35B | 43.88B | 44.45B | 40.77B | 40.96B | 39.95B | 40.11B | 34.12B | 30.14B | 26.03B | 25.82B | 24.26B | 22.85B | 19.99B | 25.12B | 23.45B | 23.15B | 23.37B | 22.06B | 21.37B | 18.52B | 16.44B | 14.64B | 12.02B | 8.4B | 7.48B | 3.09B |
| Asset Turnover | 4.45x | 4.44x | 4.19x | 5.03x | 4.73x | 4.13x | 3.65x | 3.75x | 3.55x | 3.42x | 3.24x | 3.56x | 3.40x | 3.50x | 3.92x | 4.43x | 4.49x | 4.93x | 3.82x | 3.73x | 3.75x | 3.41x | 3.29x | 3.02x | 3.06x | 3.11x | 3.27x | 3.19x | 2.99x | 2.82x | 5.95x |
| Asset Growth % | 52.92% | 7.86% | 17.73% | 4.09% | -1.21% | -1.29% | 9.04% | -0.48% | 2.53% | -0.4% | 17.55% | 13.2% | 15.78% | 0.83% | 6.43% | 6.19% | 14.29% | -20.42% | 7.12% | 1.27% | -0.94% | 5.96% | 3.23% | 15.38% | 12.67% | 12.26% | 21.78% | 43.07% | 12.39% | 141.87% | 9.44% |
| Total Current Liabilities | 46.33B | 43.9B | 38.9B | 35.64B | 33.74B | 30.55B | 27.62B | 23.61B | 24.11B | 22.89B | 21.22B | 19.7B | 17.24B | 15.12B | 14.59B | 14.17B | 13.37B | 11.54B | 12.28B | 10.39B | 11.46B | 11.58B | 9.9B | 9.37B | 7.31B | 6.81B | 6.57B | 5.55B | 2.97B | 2.73B | 1.39B |
| Accounts Payable | 40.94B | 38.28B | 34.71B | 31.76B | 29.93B | 27.13B | 23.7B | 21.37B | 21.54B | 19.68B | 17.91B | 17.31B | 14.37B | 12.15B | 12.29B | 11.73B | 11.33B | 9.49B | 9.04B | 8.3B | 9.16B | 8.91B | 7.35B | 6.43B | 5.29B | 5.5B | 5.32B | 3.9B | 2.36B | 2.14B | 1.14B |
| Days Payables Outstanding | 57.49 | 57.16 | 59.09 | 52.83 | 55.15 | 56.63 | 55.56 | 53.42 | 56.67 | 55.41 | 52.95 | 54.93 | 54.17 | 51.61 | 46.66 | 41.55 | 42 | 36.59 | 35.78 | 36.24 | 40.98 | 43.44 | 39.34 | 39.21 | 36.95 | 42.67 | 43.8 | 40.33 | 38.78 | 42.06 | 25.65 |
| Short-Term Debt | 1.89B | 1.84B | 714M | 551M | 892M | 682M | 976M | 10M | 452M | 1B | 1.33B | 587M | 281M | 801M | 168M | 476M | 326.7M | 233.2M | 367.3M | 159M | 16M | 199M | 307.9M | 860.6M | 228.7M | 18.2M | 14.2M | 423.4M | 40.2M | 32M | 28.3M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.5B | 0 | -164M | 0 | 42M | 0 | 96M | 0 | 0 | 213M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.37B | 50M | 34.2M | 534.2M | 345.5M | 55.1M | 64.3M | 0 | 0 | 0 | 561.2M | 550.7M | 225.1M |
| Current Ratio | 0.88x | 0.88x | 0.94x | 0.98x | 1.00x | 1.08x | 1.12x | 1.10x | 1.07x | 1.07x | 1.34x | 1.11x | 1.26x | 1.19x | 1.22x | 1.24x | 1.22x | 1.29x | 1.71x | 1.37x | 1.27x | 1.43x | 1.37x | 1.39x | 1.81x | 1.75x | 1.63x | 1.52x | 1.75x | 1.76x | 1.79x |
| Quick Ratio | 0.49x | 0.49x | 0.50x | 0.56x | 0.52x | 0.57x | 0.60x | 0.54x | 0.54x | 0.53x | 0.80x | 0.58x | 0.73x | 0.64x | 0.64x | 0.68x | 0.67x | 0.74x | 1.15x | 0.72x | 0.62x | 0.78x | 0.63x | 0.60x | 0.77x | 0.67x | 0.67x | 0.68x | 0.76x | 0.80x | 0.76x |
| Cash Conversion Cycle | -10.59 | -11.5 | -8.73 | -8.51 | -5.67 | -2.71 | -0.9 | -0.71 | -1.74 | 0.06 | 3.07 | 1 | 3.78 | 5.06 | 7.88 | 7.88 | 7.08 | 7.06 | 11.09 | 14.13 | 11.86 | 10.55 | 15.04 | 25.75 | 34.22 | 30.77 | 26.29 | 30.72 | 32.74 | 34.01 | 20.12 |
| Total Non-Current Liabilities | 16.08B | 16.12B | 16.86B | 12.69B | 12.57B | 14.03B | 15.04B | 15.36B | 10.52B | 11B | 12.06B | 7.85B | 6.64B | 4.52B | 5.25B | 3.84B | 3.63B | 3.18B | 4.12B | 5.31B | 4.32B | 3.36B | 3.34B | 4.02B | 3.48B | 3.23B | 2.63B | 2.08B | 1.87B | 1.8B | 367.7M |
| Long-Term Debt | 6.93B | 6.86B | 7.82B | 4.58B | 3.85B | 4.69B | 5.32B | 6.76B | 7.58B | 8.01B | 9.07B | 4.95B | 5.21B | 3.17B | 3.69B | 2.42B | 2.17B | 1.9B | 3.28B | 3.69B | 3.46B | 2.59B | 2.32B | 2.83B | 2.47B | 2.21B | 1.87B | 1.52B | 1.22B | 1.33B | 277.8M |
| Capital Lease Obligations | 1B | 1B | 811M | 475M | 434M | 437M | 419M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 24.95B | 2.31B | 2.43B | 3.09B | 3.14B | 3.02B | 8.31B | 8.59B | 2.94B | 2.98B | 2.88B | 2.78B | 1.43B | 1.35B | 1.57B | 1.42B | 1.45B | 1.28B | 847.3M | 1.63B | 859.9M | 771.9M | 1.02B | 1.19B | 1.01B | 1.03B | 759.5M | 552.5M | 645.7M | 467.7M | 89.8M |
| Other Non-Current Liabilities | 3.78B | 5.95B | 5.8B | 4.54B | 5.14B | 5.89B | 981M | 0 | 0 | 12M | 118M | 117M | 0 | 0 | 0 | 0 | 0 | 0 | -8.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100K |
| Total Liabilities | 62.41B | 60.02B | 55.76B | 48.33B | 46.31B | 44.58B | 42.66B | 38.97B | 34.63B | 33.89B | 33.28B | 27.55B | 23.89B | 19.63B | 19.84B | 18.02B | 17B | 14.71B | 16.39B | 15.7B | 15.78B | 14.94B | 13.25B | 13.39B | 10.79B | 10.04B | 9.21B | 7.62B | 4.83B | 4.52B | 1.76B |
| Total Debt | 8.81B | 9.95B | 9.35B | 5.61B | 5.18B | 5.8B | 6.71B | 6.78B | 8.03B | 9.01B | 10.39B | 5.54B | 5.49B | 3.97B | 3.85B | 2.89B | 2.5B | 2.13B | 3.65B | 3.85B | 3.47B | 2.79B | 2.63B | 3.7B | 2.7B | 2.23B | 1.89B | 1.95B | 1.26B | 1.36B | 306.1M |
| Net Debt | 3.55B | 5.09B | 5.47B | 476M | 1.1B | 1.09B | 3.31B | 4B | 5.5B | 7.25B | 3.52B | 3.18B | 876M | 1.11B | 1.95B | 620M | 572.7M | -626M | 2.42B | 2.56B | 2.16B | 1.6B | 1.23B | 2.6B | 976.6M | 843.2M | 951.1M | 1.41B | 1.08B | 988.7M | 63M |
| Debt / Equity | -3.08x | - | - | - | - | - | 3.74x | 3.78x | 1.27x | 1.49x | 1.52x | 0.84x | 0.88x | 0.62x | 0.65x | 0.46x | 0.43x | 0.40x | 0.42x | 0.50x | 0.47x | 0.33x | 0.31x | 0.46x | 0.35x | 0.35x | 0.35x | 0.44x | 0.35x | 0.46x | 0.23x |
| Debt / EBITDA | 2.40x | 2.79x | 3.05x | 2.87x | 3.58x | 68.29x | 5.35x | - | 2.62x | 7.78x | 3.66x | 1.79x | 2.10x | 1.69x | 2.77x | 1.37x | 1.37x | 1.36x | 2.41x | 2.39x | 2.05x | 1.30x | 1.26x | 1.41x | 1.10x | 1.07x | 1.07x | 1.27x | 0.99x | 1.27x | 0.33x |
| Net Debt / EBITDA | 0.97x | 1.43x | 1.78x | 0.24x | 0.76x | 12.80x | 2.64x | - | 1.80x | 6.26x | 1.24x | 1.03x | 0.34x | 0.47x | 1.40x | 0.29x | 0.31x | -0.40x | 1.60x | 1.58x | 1.28x | 0.75x | 0.59x | 0.99x | 0.40x | 0.41x | 0.54x | 0.92x | 0.84x | 0.92x | 0.07x |
| Interest Coverage | 7.64x | 7.25x | 10.77x | 24.55x | 8.89x | -4.33x | 2.79x | -14.85x | 6.96x | 0.31x | 10.57x | 13.79x | 14.95x | 14.52x | 8.22x | 18.87x | 17.32x | 11.73x | 6.47x | 10.55x | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | -2.87B | -2.72B | -2.63B | -3.21B | -2.96B | -706M | 1.79B | 1.79B | 6.33B | 6.06B | 6.83B | 6.57B | 6.26B | 6.4B | 5.97B | 6.24B | 5.85B | 5.28B | 8.72B | 7.75B | 7.38B | 8.49B | 8.59B | 7.98B | 7.67B | 6.39B | 5.44B | 4.4B | 3.57B | 2.95B | 1.33B |
| Equity Growth % | -41.57% | -3.42% | 18% | -8.62% | -318.84% | -139.35% | 0.11% | -71.69% | 4.47% | -11.26% | 3.91% | 5.04% | -2.27% | 7.13% | -4.31% | 6.75% | 10.86% | -39.53% | 12.61% | 5.02% | -13.12% | -1.19% | 7.73% | 3.93% | 20.05% | 17.58% | 23.56% | 23.27% | 20.8% | 121.39% | 28.86% |
| Book Value per Share | -12.30 | -11.49 | -10.88 | -13.00 | -11.29 | -2.53 | 6.10 | 6.12 | 21.03 | 19.23 | 21.34 | 19.91 | 18.67 | 18.55 | 17.37 | 17.89 | 16.59 | 14.60 | 24.13 | 21.28 | 18.23 | 19.81 | 19.71 | 18.55 | 16.91 | 14.10 | 11.73 | 9.69 | 8.34 | 7.09 | 5.60 |
| Total Shareholders' Equity | -3.02B | -2.88B | -2.78B | -3.21B | -2.96B | -709M | 1.79B | 1.79B | 6.33B | 6.06B | 6.81B | 6.55B | 6.26B | 6.4B | 5.97B | 6.24B | 5.85B | 5.28B | 8.72B | 7.75B | 7.38B | 8.49B | 8.59B | 7.98B | 7.67B | 6.39B | 5.44B | 4.4B | 3.57B | 2.95B | 1.33B |
| Common Stock | 2.77B | 2.89B | 2.96B | 2.92B | 2.75B | 2.81B | 2.81B | 2.79B | 2.76B | 2.73B | 2.7B | 3.01B | 3B | 2.98B | 2.95B | 2.93B | 2.9B | 0 | 0 | 0 | 0 | 0 | 2.77B | 2.65B | 2.4B | 2.11B | 1.89B | 1.51B | 1.09B | 1.06B | 0 |
| Retained Earnings | 2.44B | 2.01B | 783M | -286M | -642M | -280M | 1.21B | 1.17B | 5.43B | 4.64B | 4.97B | 6.42B | 5.52B | 4.77B | 4.04B | 4.09B | 3.33B | 2.65B | 5.95B | 5.02B | 11.54B | 9.76B | 8.87B | 7.89B | 6.47B | 5.16B | 4.15B | 3.33B | 2.54B | 2.01B | 701.9M |
| Treasury Stock | -8.08B | -7.61B | -6.37B | -5.68B | -4.91B | -3.13B | -2.19B | -2.07B | -1.79B | -1.22B | -731M | -2.76B | -2.25B | -1.42B | -1.08B | -816M | -457.7M | -331M | -343M | -480.7M | -8.22B | -4.5B | -3.04B | -2.59B | -1.14B | -737M | -457.2M | -346.6M | -17.2M | -82.3M | 0 |
| Accumulated OCI | -159M | -165M | -155M | -167M | -151M | -114M | -34M | -104M | -79M | -92M | -125M | -116M | -23M | 70M | 68M | 37M | 77M | 70M | 82.2M | 210.8M | 121M | 33.9M | -3.1M | 22.6M | -58.6M | -131.3M | -144.8M | -94.3M | -49M | -33.3M | 0 |
| Minority Interest | 159M | 159M | 147M | 1M | 1M | 3M | 3M | 3M | 2M | 0 | 20M | 17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CAH stock.
As of 2026, Cardinal Health, Inc. (CAH) had total assets of $57.30B including $38.75B in current assets.
Cardinal Health, Inc. (CAH) carries total debt of $9.95B, offset by $4.86B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Cardinal Health, Inc. (CAH) has total shareholders' equity (book value) of $-2883.0M ($-11.49 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Cardinal Health, Inc. (CAH) reported a current ratio of 0.88x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Negative equity with thin margins
Metrics are mathematically derived from official filings.
Negative Equity Persists Despite Earnings Recovery
Based on reported quarterly balance sheets, CAH's equity remained negative at roughly -$2.8B to -$3.3B across all ten quarters, while retained earnings recovered from -$286M to $2.4B, suggesting the balance sheet is strengthening at the retained earnings line but not yet at the total equity level.
The shift in retained earnings from deficit to a $2.4B surplus is a meaningful directional signal, consistent with the earnings improvement noted in prior income statement findings. However, total equity has not moved meaningfully positive, which implies that buybacks, dividends, or other equity reductions are offsetting retained earnings gains. Investors should monitor whether the retained earnings trajectory can translate into positive total equity over time.
Leverage Stable as Debt Tracks Cash Position
As reported in the financial statements, total debt has held between roughly $5.2B and $9.9B over the period, with debt rising in step with cash balances, which may indicate that borrowing is partly used to fund working capital needs rather than being purely strategic.
The negative equity base makes conventional D/E ratios uninformative, so leverage should be assessed against cash flow capacity rather than book equity. The correlation between debt and cash build-ups suggests that periodic borrowing may be tied to working capital cycles. Given the volatility in operating cash flow documented in prior cash flow findings, refinancing or rate exposure warrants continued monitoring.
Current Ratio Below Parity Throughout Period
According to reported figures, CAH's current ratio has remained between 0.88 and 1.02 across the ten quarters, with cash balances ranging from $2.8B to $5.3B, suggesting short-term liabilities consistently approximate or exceed current assets.
A current ratio near or below 1.0 is typical for a high-velocity distributor that turns inventory quickly and relies on supplier credit, so this pattern alone does not indicate distress. The cash position relative to the quarterly cost base, however, is thin buffer against shocks. Liquidity appears adequate under normal operating conditions but may be more sensitive to working capital reversals than headline ratios suggest.
Goodwill Build Raises Impairment Sensitivity
Based on EDBL-style reported balance sheet figures, goodwill rose from roughly $4.7B to $13.6B over the period while net PPE stayed near $2.5B to $4.0B, indicating that the asset base has become increasingly weighted toward acquired intangibles rather than physical capacity.
A sharp increase in goodwill relative to tangible PPE suggests acquisition activity has been a material driver of asset growth, which carries impairment risk if acquired businesses underperform. Given the company's documented history of impairments in its Medical segment, this asset mix warrants scrutiny. Investors should evaluate whether the goodwill base is supported by realistic forward cash flows from the acquired operations.
Headline Assets Mask Negative Net Worth
As reported in the quarterly statements, total assets grew from roughly $43B to $59B while total liabilities exceeded assets in every period, which may suggest the balance sheet expansion is financed largely by obligations rather than shareholder capital.
Asset growth alone can be misleading when liabilities grow at a similar or faster pace, and here liabilities exceed assets throughout the period. The growth in goodwill, which is intangible and subject to impairment, makes the asset base less reliable as a collateral or loss-absorption buffer. This pattern warrants further investigation into the composition and maturity profile of liabilities.